 Outstanding offer to purchase Startek for 5.40 or 86 premium to current prices. Offer is at a 5.4 EVEBITDA which is low compared to industry average between 6.5-8.5. Near-term catalyst given acquiring company set to announce if they have financing before the end of August. 